Verastem (VSTM) Research & Development (2011 - 2026)

Verastem (VSTM) recorded quarterly Research & Development of $38.2 million in Q1 2026, up 20.66% quarter-over-quarter from $31.7 million in Q4 2025, and up 31.1% on a YoY basis from $29.2 million in Q1 2025.

Verastem (VSTM) Research & Development (2011 - 2026) Analysis & Trends

Verastem's Research & Development history runs 16 years deep, the most recent figure standing at $38.2 million for Q1 2026.

  • In Q1 2026, Research & Development rose 31.1% year-over-year to $38.2 million; the TTM figure through Mar 2026 stood at $123.7 million (up 33.29% YoY), while the FY2025 annual figure was $114.6 million, up 40.9% from the prior year.
  • Research & Development was $38.2 million for Q1 2026 at Verastem, up from $31.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $38.2 million in Q1 2026 to a low of $10.7 million in Q4 2022.
  • Historically, Research & Development has averaged $20.4 million across 5 years, with a median of $18.1 million in 2024.
  • Biggest YoY gain for Research & Development was 109.52% in 2023; the steepest drop was 13.4% in 2023.
  • A 5-year view of Research & Development shows it stood at $10.7 million in 2022, then soared by 109.52% to $22.5 million in 2023, then retreated by 7.51% to $20.8 million in 2024, then surged by 52.2% to $31.7 million in 2025, then gained by 20.66% to $38.2 million in 2026.
  • The last three Research & Development figures came in at $38.2 million (Q1 2026), $31.7 million (Q4 2025), and $29.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 4.32 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 15.66 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 626,092.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -101.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -2.30 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 1.46 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 357,444.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 961.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -58.00 Mn
10 Verastem 407.42 Mn 225.74 Mn 15.90 Mn 38.22 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 38.22 Mn
Dec 31, 2025 31.67 Mn
Sep 30, 2025 28.99 Mn
Jun 30, 2025 24.79 Mn
Mar 31, 2025 29.15 Mn
Dec 31, 2024 20.81 Mn
Sep 30, 2024 24.75 Mn
Jun 30, 2024 18.06 Mn
Mar 31, 2024 17.71 Mn
Dec 31, 2023 22.50 Mn
Sep 30, 2023 13.95 Mn
Jun 30, 2023 12.89 Mn
Mar 31, 2023 12.02 Mn
Dec 31, 2022 10.74 Mn
Sep 30, 2022 11.29 Mn
Jun 30, 2022 14.89 Mn
Mar 31, 2022 13.64 Mn
Dec 31, 2021 11.40 Mn
Sep 30, 2021 9.33 Mn
Jun 30, 2021 9.73 Mn